logo

For the Inventor, By the Inventor

Dieburg, Germany

Franz Hock

USPTO Granted Patents = 12

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal12 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1986-1997

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5648333 - Peptides having bradykinin antagonist action (1997-07-15),
2. 5231084 - Compounds having a cognition adjuvant action, agents containing them, (1993-07-27),
3. 5114962 - New amino acid esters, a process for their preparation, medicaments (1992-05-19),
4. 5091427 - Piperazinediones having a psychotropic action (1992-02-25),
5. 5068242 - Pyrrolidine-2-carboxylic acid derivatives and their use for psychotropic (1991-11-26),
6. 5055483 - Novel amino acid glycerides, learning medicaments containing them and (1991-10-08),
7. 5043346 - Amino acid esters, pharmaceuticals containing them, and the use thereof (1991-08-27),
8. 4999370 - Compounds with a psychotropic action, agents containing them, and the (1991-03-12),
9. 4983623 - Derivatives of cyclic amino acids, agents containing them, and the use (1991-01-08),
10. 4912128 - Novel pyrrolidine-2-(1,3-dicarbonyl) derivatives, a process for their (1990-03-27),
11. 4912127 - New 2-acylpyrrolidine derivatives, a process for the preparation (1990-03-27),
12. 4590273 - Isoquinoline compounds (1986-05-20),

Title: Franz Hock: Innovator in Cognition Adjuvant Research

Introduction

Franz Hock is a distinguished inventor based in Dieburg, Germany, known for his impactful contributions in the field of biochemistry and pharmacology. With an impressive portfolio of 12 patents, Hock has made significant strides in developing compounds that combat cognitive dysfunctions.

Latest Patents

Among his latest innovations, Hock has developed peptides demonstrating bradykinin antagonist action. He has also introduced compounds with cognition adjuvant properties, which are pivotal in the treatment and prevention of cognitive dysfunctions. These inventions not only highlight his expertise but also underscore the potential applications of his research in medicinal chemistry.

Career Highlights

Franz Hock is currently employed at Hoechst Aktiengesellschaft, where he has collaborated with leading figures in the field. His work there has focused on advancing our understanding of cognitive enhancers and their therapeutic applications.

Collaborations

Throughout his career, Hock has worked alongside notable colleagues such as Hansjorg Urbach and Rainer Henning. These collaborations have been instrumental in pushing the boundaries of research and innovation, leading to breakthroughs in cognitive health.

Conclusion

Franz Hock's contributions to science, particularly in the development of cognition adjuvants, demonstrate the vital role inventors play in advancing healthcare solutions. His ongoing dedication to research at Hoechst Aktiengesellschaft continues to foster innovation that may significantly impact the treatment of cognitive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…